Ancora Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $49.7K | Hold |
|
|||||
|
2025
Q2 | $50.5K | Sell |
|
|||||
|
2025
Q1 | $70.2K | Sell |
|
|||||
|
2024
Q4 | $85K | Sell |
|
|||||
|
2024
Q3 | $115K | Sell |
|
|||||
|
2024
Q2 | $148K | Hold |
|
|||||
|
2024
Q1 | $157K | Buy |
|
|||||
|
2023
Q4 | $169K | Sell |
|
|||||
|
2023
Q3 | $168K | Hold |
|
|||||
|
2023
Q2 | $165K | Hold |
|
|||||
|
2023
Q1 | $185K | Hold |
|
|||||
|
2022
Q4 | $197K | Sell |
|
|||||
|
2022
Q3 | $178K | Sell |
|
|||||
|
2022
Q2 | $176K | Sell |
|
|||||
|
2022
Q1 | $171K | Sell |
|
|||||
|
2021
Q4 | $207K | Buy |
|
|||||
|
2021
Q3 | $33K | Buy |
|
|||||
|
2021
Q2 | $6K | Hold |
|
|||||
|
2021
Q1 | $6K | Hold |
|
|||||
|
2020
Q4 | $7K | Sell |
|
|||||
|
2020
Q3 | $21K | Hold |
|
|||||
|
2020
Q2 | $34K | Hold |
|
|||||
|
2020
Q1 | $23K | Buy |
|